Y150

· Wuhan YZY Biopharma Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Y150, covering 2025-07-20 to 2025-07-20. Get the full timeline:

Most recent: Clinical Trial Update: A Phase I Clinical Trial of Y150 in the Treatment of Relapsed or Refractory Multiple Myeloma [Phase 1]